One of the most widespread cancer diseases in Women globally is Cervical Cancer. Cervical cancer is a disease with the long hidden era, early on recognition and care of precancerous lesions were extremely effective in women who often take screening tests. Mostly in many incidences, the disease is recognized as Human Papilloma Virus (HPV)infection. But in many developed nations, the death rate because of cervical cancer screening has fallen down. Global Cervical Cancer Screening Market is forecast to be US$ 7 Billion by 2020.
How Cervical Cancer Occurs & their Symptoms
In cervical cancer malignant tumor is in the lower most part of the uterus (womb). Symptoms consist of bleeding in between periods and after sexual intercourse. Pain may also occur in lower back pain or lower abdominal and foul smelling white discharge. There are many cases when there are no symptoms found.
The Cervical cancer can be prevented by HPV vaccine as well as PAP smear screening. Surgery, Chemotherapy and Radiation are the treatment for cervical cancer. Ages and their occurrence can be distinguished in following manners.
Ages Occurrences0 to2 Never
3 to 5 Never
6 to 13 Never
14 to 18 Very Rare
19 to 40 Rare
41 to 60 Rare
The Cervical cancer test includes Human Papilloma Virus (HPV) vaccine and PAP smear screening. Surgery, Chemotherapy and Radiation are the treatment for cervical cancer. Human Papilloma Virus (HPV) test occurs when the symptoms of HPV mainly causes infection in mouth, hand, genitals and fingers. Globally focus on HPV testing because of the rising awareness about and the link between HPV and Cervical cancer. PAP smear screening, been widely used as primary screening test for cervical cancer treatments. Changing the center on HPV testing as the primary screening test because of lower test sensitivity, higher negative results etc.
Cervical Cancer Test Market & Market Share: Overview
In Cervical cancer market 50 percent of the market share is jointly captured by the United States and Japan. In market research report, published by Renub Research found that Japan market will decline in future. The United Kingdom and France lead the cervical cancer market in Europe. Nations like India, China and Indonesia captures most of the cervical cancer test population.
Challenges in Cervical Cancer Globally
Globally challenges of cervical cancer are the scarcity of gynecologists and pathologists, lack of awareness of diseases, lack of government facilities and policies in low income nations.
The Report Studies the Global Cervical Cancer Screening Market on the basis of:
Countries1. United Kingdom
10. United States
Cervical Cancer Test Market
• HPV DNA Test Market & Forecast
• VIA Test Market & Forecast
Sr. Marketing Manager
Renub Research is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others.
Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today’s ultra-competitive markets.